TG’s Follicular Lymphoma Data Suggest Umbralisib Could Succeed In PI3K Delta Class

 
• By Joseph Haas
Follicular lymphoma is one of mature B-cell neoplasm
TG Therapeutics hopes it can provide a safer, more tolerable follicular lymphoma therapy

More from Clinical Trials

More from R&D